From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine (Q24737418)
scientific article published on July 13, 2011
Language:
(P31) (Q13442814)
(P304) 7229-7241
(P407) (Q1860)
(P433) 42
(P478) 29
(P577) Friday, September 23, 2011
Wednesday, July 13, 2011
(P921) (Q27133094)
(Q476209)
(Q134808)
(P953) https://api.elsevier.com/content/article/PII:S0264410X11009881?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0264410X11009881?httpAccept=text/plain
(P1104) 13
(P1433) (Q7907941)
(P1476) "From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine" (language: en)
"From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine" (language: en)
(P2093) Bruno Guy
Beatrice Barrere
Claire Malinowski
Melanie Saville
Remy Teyssou
Jean Lang
(P2860) (Q28298464)
(Q37827145)
(Q37625323)
(Q27469664)
(Q37609595)
(Q37791334)
(Q37423499)
(Q40472170)
(Q40543244)
(Q40318846)
(Q34610002)
(Q27472880)
(Q40505402)
(Q29619564)
(Q27469896)
(Q40516020)
(Q35097474)
(Q34416579)
(Q37819533)
(Q40480637)
(Q27485295)
(Q28513232)
(Q33796488)
(Q42991074)
(Q34402910)
(Q27860703)
(Q39887927)
(Q37162404)
(Q80962043)
(Q40468558)
(Q40369287)
(Q40410592)
(Q40344756)
(Q38931449)
(Q35246126)
(Q34763787)
(Q36581319)
(Q40579912)
(Q40502077)
(Q34754885)
(Q40329672)
(Q29619585)
(Q33389673)
(Q37330751)
(Q35811332)
(Q42986790)
(Q42991651)
(Q27490533)
(Q40427312)
(Q27487448)
(Q40884212)
(Q40527785)
(Q34013868)
(Q28476176)
(Q28473212)
(Q40353783)
(Q33769927)
(Q37047163)
(Q28751949)
(Q33539104)
(Q82380629)
(Q42622939)
(Q27469353)
(Q40463857)
(Q29619530)
(P5008) (Q55439927)
(P13046) (Q7318358)
other details
description scientific article published on July 13, 2011

External Links